Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
282
|
1613
|
0.100 |
None |
1.000 |
6 |
221
|
2007 |
2014 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
201
|
488
|
0.100 |
None |
1.000 |
5 |
27
|
2007 |
2013 |
Sarcoidosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
20
|
697
|
0.100 |
None |
1.000 |
3 |
68
|
2008 |
2016 |
Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
61
|
121
|
0.100 |
None |
1.000 |
3 |
3
|
2010 |
2012 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
202
|
436
|
0.100 |
None |
1.000 |
2 |
17
|
2009 |
2010 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
66
|
166
|
0.100 |
None |
1.000 |
2 |
1
|
2009 |
2012 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
109
|
253
|
0.100 |
None |
1.000 |
2 |
10
|
2008 |
2014 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
43
|
80
|
0.100 |
None |
1.000 |
2 |
3
|
2009 |
2016 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
4
|
2009 |
2010 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
4
|
2009 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
4
|
2009 |
2010 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
4
|
2009 |
2010 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
5
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
212
|
258
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2016 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
19
|
33
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Lung Diseases, Interstitial
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
31
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Non-obstructive azoospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
26
|
48
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
9
|
22
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Anti-cyclic citrullinated peptide antibody
|
phenotype |
|
Laboratory Procedure
|
2
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
4
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
55
|
819
|
0.100 |
None |
1.000 |
1 |
21
|
2013 |
2013 |
Osteoarthritis, Knee
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
2
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
17
|
54
|
0.100 |
None |
1.000 |
1 |
8
|
2013 |
2013 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
110
|
263
|
0.100 |
None |
1.000 |
1 |
3
|
2011 |
2017 |
Bone Density
|
phenotype |
|
Clinical Attribute
|
22
|
350
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |